Subscribe To
Actinium pharmaceuticals: the trickle down continues, and i maintain a buy
Actinium Pharmaceuticals continues to make progress with their radiolabelled CD45 antibody Iomab-B, which has potential beyond market expectations. Th...
November 3, 2023, 6:08 pm
Pembina pipeline corporation (pba) q3 2023 earnings call transcript
Pembina pipeline Corporation (NYSE:PBA ) Q3 2023 Earnings Conference Call November 3, 2023 10:00 AM ET ...
November 3, 2023, 4:35 pm
Plains all american reports third-quarter 2023 results & raises 2023 guidance
Announces Capital Allocation Updates & Permian Bolt-On Acquisitions HOUSTON, Nov. 03, 2023 (GLOBE NEWSWIRE) — Plains All American ...
November 3, 2023, 11:30 am
Plains all american (paa) q3 earnings top estimates, sales lag
Plains All American pipeline's (PAA) Q3 earnings surpass estimates. The company raises its 2023 guidanc...
November 3, 2023, 11:18 am
Enbridge 3q profit tops estimates on higher transport volumes
Enbridge Inc (TSX:ENB) on Friday announced third quarter 2023 adjusted earnings per share (EPS) of C$0.62, surpassing the consensus forecast of C$0.60...
November 3, 2023, 9:56 am
pipeline operator enbridge beats profit targets on higher transport volumes
pipeline operator Enbridge on Friday beat third-quarter profit estimates, helped by higher volumes of o...
November 3, 2023, 7:05 am
3 dividend-paying energy stocks to buy hand over fist in november
pipeline owner Enterprise Products Partners is a high-yield toll taker. ExxonMobil is a reliable energy...
November 3, 2023, 4:52 am
pipeline moves: approval prospects rise for oesophageal cancer drug after trial completion
On a good note, we investigate the completion of a Phase IIb trial in congestive heart failure and chronic kidney disease, a Phase II trial in triple-...
November 2, 2023, 8:29 pm
Regenxbio: biotech to watch with 2 possible accelerated approval pathways
Regenxbio Inc. is making progress in its pipeline, aiming to have five gene therapies in late-stage tes...
November 2, 2023, 5:33 pm
Apple's loaded product lineup headed into the holidays is good news for investors
Apple could benefit from a jam-packed product pipeline and a healthy global supply chain during fiscal ...
November 2, 2023, 5:06 am
Acorn, provider of remote monitoring, control and electrical grid demand response solutions for backup generators, hosts q3 investor call thur., nov. 9th at 11am et
WILMINGTON, Del., Nov. 01, 2023 (GLOBE NEWSWIRE) — Acorn Energy, Inc. (OTCQB: ACFN), a provider of remote monitoring and control solutions for stand...
November 1, 2023, 6:28 pm
Oneok, inc. (oke) q3 2023 earnings call transcript
ONEOK, Inc. (NYSE:OKE ) Q3 2023 Earnings Conference Call November 1, 2023 11:00 AM ET Company Participants Andrew Ziola - Vice President, Investor Rel...
November 1, 2023, 3:52 pm
Ibio further expands tech stack with shieldtx™; enhances immuno-oncology development pipeline with conditionally activated muc16xcd3 bispecific
– ShieldTx potentially increases safety and developability of therapeutic antibodies for difficult targets and modes of action – BRYAN, Texas and ...
November 1, 2023, 12:24 pm
Enterprise products partners: buy this 8%-yielding blue-chip before everyone else does
Buying companies that pay sustainable dividends or distributions at deep discounts tends to work well over the long haul. Enterprise Products Partners...
November 1, 2023, 10:52 am
Aptevo to present at bio-europe conference
SEATTLE, WA / ACCESSWIRE / November 1, 2023 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing nov...
November 1, 2023, 7:45 am
What awaits plains all american pipeline (paa) in q3 earnings?
Plains All American pipeline's (PAA) third-quarter earnings are likely to have benefited from the acqui...
November 1, 2023, 7:31 am
Apnimed announces launch of joint venture with shionogi to develop novel pharmacologic therapies for obstructive sleep apnea and other sleep disorders
$150M transaction supporting early and clinical-stage pipeline development in OSA and related sleep dis...
November 1, 2023, 12:00 am
Mersana therapeutics to host third quarter 2023 conference call on november 7, 2023
CAMBRIDGE, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on d...
October 31, 2023, 4:30 pm
Analyzing the acquisition potential of immunogen
ImmunoGen, Inc.'s marketing authorization application for ELAHERE, a cancer therapy, has been accepted by the EMA. Rumors suggest that large European ...
October 31, 2023, 3:25 pm
Enterprise products doubles down on gas liquids with pipelines, processing plants
Energy pipeline operator Enterprise Products Partners will expand its natural gas liquids (NGLs) operat...
October 31, 2023, 12:17 pm